Articles producció científicaInfermeria

HPV Vaccination Coverage Rate in a Rural Area: An Observational, Retrospective, and Cohort Study

  • Identification data

    Identifier:  imarina:9280937
    Authors:  Colome-Ceballos, Lara; Clua-Espuny, Josep Lluis; Fernandez-Saez, Jose; Ceballos-Garcia, Concepcion; Andres-Cubells, Natalia; Pla-Farnos, Maria Jesus
    Abstract:
    In order to reduce the incidence and mortality rate of cervical cancer, the World Health Organization (WHO) declared the Global Strategy Goal for 2030, advocating for reaching a vaccination coverage rate of >90% against human papillomavirus for girls by the age of 15 years. The main objectives of this study were (1) to determine the papillomavirus vaccination coverage among women 15-40 years old and (2) to identify the at-risk subgroups and possible barriers to achieving WHO's 2030 goal. Multicentre, observational, retrospective, and community-based cohort studies were conducted on women from a rural area in southern Catalonia until 31 December 2021. A total of 23,136 women were included, with a mean age of 26.6 (SD = 5.6) years. The average dose number was 1.7 (SD = 0.7). The results showed overall vaccination coverage of 17.4% among the target women. This coverage was unequal across regions (16.6-24.5%, p < 0.001), primary healthcare teams (15.5-24.3%, p < 0.001), and age groups (56.7% (15-19-year-olds) vs. 3.8% (35-40-year-olds), p < 0.001), related to accessibility to vaccination and economic-geographical indicators. Clinical practice guidelines on screening individuals at risk in terms of vaccination access and public vaccination protocols should be implemented in order to improve the vaccination coverage rate.
  • Others:

    Link to the original source: https://www.mdpi.com/2076-393X/10/8/1274
    APA: Colome-Ceballos, Lara; Clua-Espuny, Josep Lluis; Fernandez-Saez, Jose; Ceballos-Garcia, Concepcion; Andres-Cubells, Natalia; Pla-Farnos, Maria Jesus (2022). HPV Vaccination Coverage Rate in a Rural Area: An Observational, Retrospective, and Cohort Study. Vaccines, 10(8), 1274-. DOI: 10.3390/vaccines10081274
    Paper original source: Vaccines. 10 (8): 1274-
    Article's DOI: 10.3390/vaccines10081274
    Journal publication year: 2022
    Entity: Universitat Rovira i Virgili
    Paper version: info:eu-repo/semantics/publishedVersion
    Record's date: 2025-03-15
    URV's Author/s: Fernández Sáez, José
    Department: Infermeria
    Licence document URL: https://repositori.urv.cat/ca/proteccio-de-dades/
    Publication Type: Journal Publications
    Author, as appears in the article.: Colome-Ceballos, Lara; Clua-Espuny, Josep Lluis; Fernandez-Saez, Jose; Ceballos-Garcia, Concepcion; Andres-Cubells, Natalia; Pla-Farnos, Maria Jesus
    licence for use: https://creativecommons.org/licenses/by/3.0/es/
    Thematic Areas: Drug discovery, Immunology, Infectious diseases, Medicine, research & experimental, Pharmacology, Pharmacology (medical)
    Author's mail: jose.fernandezs@urv.cat, jose.fernandezs@urv.cat
  • Keywords:

    Access
    Barriers
    Burden
    Cancer
    Coverage
    Equity
    Human-papillomavirus
    Papillomavirus
    Precancerous lesions
    Vaccination
    Women
    Drug Discovery
    Immunology
    Infectious Diseases
    Medicine
    Research & Experimental
    Pharmacology
    Pharmacology (Medical)
  • Documents:

  • Cerca a google

    Search to google scholar